Bio-Rad to Acquire MJ GeneWorks and Subsidiaries for $47M, Liabilities

genomeweb
360dx

Bio-Rad to Acquire MJ GeneWorks and Subsidiaries for $47M, Liabilities

Jun 02, 2004

NEW YORK, June 2 (GenomeWeb News) - Bio-Rad Laboratories plans to acquire MJGeneWorks and its subsidiaries for $47 million in cash, the company said today. MJGeneWorks is the parent company of MJ Research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Molecular Profiling of Cancer Patients Uncovers Combination Treatments in I-PREDICT Study
Liquid Biopsy Utility Reinforced in Early Results From UK TARGET Program
Enzo, Hologic, Grifols Settle Patent Dispute
Checkpoint Immunotherapy Response Described in Tumors with Gene Fusion-Based Neoantigens
Top Five Articles on GenomeWeb Last Week: UK Investigating Illumina-PacBio Deal; Inova Ends PGx Test
Active Celiac Disease Processes Informed by Intestinal Expression Comparison

The Scan

Pushed Aside

The New York Times Magazine examines gender discrimination at the Salk Institute.

Dismissals at MD Anderson

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

Looking Into It

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

This Week in PLOS

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.

Menu